![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 6640 |
FusionGeneSummary for CDKN2A_MGA |
![]() |
Fusion gene information | Fusion gene name: CDKN2A_MGA | Fusion gene ID: 6640 | Hgene | Tgene | Gene symbol | CDKN2A | MGA | Gene ID | 1029 | 23269 |
Gene name | cyclin dependent kinase inhibitor 2A | MGA, MAX dimerization protein | |
Synonyms | ARF|CDK4I|CDKN2|CMM2|INK4|INK4A|MLM|MTS-1|MTS1|P14|P14ARF|P16|P16-INK4A|P16INK4|P16INK4A|P19|P19ARF|TP16 | MAD5|MXD5 | |
Cytomap | 9p21.3 | 15q15.1 | |
Type of gene | protein-coding | protein-coding | |
Description | cyclin-dependent kinase inhibitor 2ACDK4 inhibitor p16-INK4alternative reading framecell cycle negative regulator betacyclin-dependent kinase 4 inhibitor Acyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)multiple tumor suppressor 1 | MAX gene-associated proteinMAX dimerization protein 5 | |
Modification date | 20180527 | 20180519 | |
UniProtAcc | Q8N726 | Q8IWI9 | |
Ensembl transtripts involved in fusion gene | ENST00000361570, ENST00000304494, ENST00000579755, ENST00000579122, ENST00000578845, ENST00000530628, ENST00000498124, ENST00000498628, ENST00000494262, ENST00000446177, ENST00000479692, ENST00000497750, ENST00000470819, | ENST00000568630, ENST00000545763, ENST00000389936, ENST00000219905, ENST00000566586, ENST00000570161, | |
Fusion gene scores | * DoF score | 11 X 4 X 9=396 | 3 X 3 X 3=27 |
# samples | 11 | 4 | |
** MAII score | log2(11/396*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/27*10)=0.567040592723894 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: CDKN2A [Title/Abstract] AND MGA [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CDKN2A | GO:0000082 | G1/S transition of mitotic cell cycle | 10208428 |
Hgene | CDKN2A | GO:0007050 | cell cycle arrest | 15149599 |
Hgene | CDKN2A | GO:0008285 | negative regulation of cell proliferation | 15149599 |
Hgene | CDKN2A | GO:0030308 | negative regulation of cell growth | 10208428 |
Hgene | CDKN2A | GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 10353611 |
Hgene | CDKN2A | GO:0042326 | negative regulation of phosphorylation | 8259215|10208428 |
Hgene | CDKN2A | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 7739547|8259215 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BLCA | TCGA-GC-A3RD-01A | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-intron | ENST00000361570 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000361570 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000361570 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000361570 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000361570 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000361570 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000304494 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000304494 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000304494 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000304494 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000304494 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000304494 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000579755 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000579755 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000579755 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000579755 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000579755 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
3UTR-intron | ENST00000579755 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000579122 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000579122 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000579122 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000579122 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000579122 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000579122 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000578845 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000578845 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000578845 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000578845 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000578845 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000578845 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000530628 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000530628 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000530628 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000530628 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000530628 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000530628 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498124 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498124 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498124 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498124 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498124 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498124 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498628 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498628 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498628 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498628 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498628 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000498628 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000494262 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000494262 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000494262 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000494262 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000494262 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000494262 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000446177 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000446177 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000446177 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000446177 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000446177 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000446177 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000479692 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000479692 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000479692 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000479692 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000479692 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
5CDS-intron | ENST00000479692 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000497750 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000497750 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000497750 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000497750 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000497750 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000497750 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000470819 | ENST00000568630 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000470819 | ENST00000545763 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000470819 | ENST00000389936 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000470819 | ENST00000219905 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000470819 | ENST00000566586 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
intron-intron | ENST00000470819 | ENST00000570161 | CDKN2A | chr9 | 21970901 | - | MGA | chr15 | 42019378 | + |
Top |
FusionProtFeatures for CDKN2A_MGA |
![]() |
Hgene | Tgene |
CDKN2A | MGA |
Capable of inducing cell cycle arrest in G1 and G2phases. Acts as a tumor suppressor. Binds to MDM2 and blocks itsnucleocytoplasmic shuttling by sequestering it in the nucleolus.This inhibits the oncogenic action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependenttransactivation and apoptosis. Also induces G2 arrest andapoptosis in a p53-independent manner by preventing the activationof cyclin B1/CDC2 complexes. Binds to BCL6 and down-regulatesBCL6-induced transcriptional repression. Binds to E2F1 and MYC andblocks their transcriptional activator activity but has no effecton MYC transcriptional repression. Binds to TOP1/TOPOI andstimulates its activity. This complex binds to rRNA gene promotersand may play a role in rRNA transcription and/or maturation.Interacts with NPM1/B23 and promotes its polyubiquitination anddegradation, thus inhibiting rRNA processing. Interacts withCOMMD1 and promotes its 'Lys63'-linked polyubiquitination.Interacts with UBE2I/UBC9 and enhances sumoylation of a number ofits binding partners including MDM2 and E2F1. Binds to HUWE1 andrepresses its ubiquitin ligase activity. May play a role incontrolling cell proliferation and apoptosis during mammary glanddevelopment. Isoform smARF may be involved in regulation ofautophagy and caspase-independent cell death; the short-livedmitochondrial isoform is stabilized by C1QBP.{ECO:0000269|PubMed:11314011, ECO:0000269|PubMed:11314038,ECO:0000269|PubMed:12660818, ECO:0000269|PubMed:14636574,ECO:0000269|PubMed:15361825, ECO:0000269|PubMed:15567177,ECO:0000269|PubMed:15876874, ECO:0000269|PubMed:15989956,ECO:0000269|PubMed:16713577, ECO:0000269|PubMed:18305112,ECO:0000269|PubMed:22094112, ECO:0000269|PubMed:9724636}. | Functions as a dual-specificity transcription factor,regulating the expression of both MAX-network and T-box familytarget genes. Functions as a repressor or an activator. Binds to5'-AATTTCACACCTAGGTGTGAAATT-3' core sequence and seems to regulateMYC-MAX target genes. Suppresses transcriptional activation by MYCand inhibits MYC-dependent cell transformation. Function activatedby heterodimerization with MAX. This heterodimerization serves thedual function of both generating an E-box-binding heterodimer andsimultaneously blocking interaction of a corepressor (Bysimilarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CDKN2A_MGA |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CDKN2A_MGA |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CDKN2A | PPP1R9B, CDK4, AURKA, CDK6, CCND2, SERTAD1, MDM2, RPL11, TP53, UBE2A, FKBP2, CCND1, E4F1, CCNG1, MDM4, ING4, DAXX, TOP1, PSME3, PSMC3, LAMTOR3, SMARCA4, ING1, KAT5, YY1, NPM1, SAP25, TRIP12, HUWE1, PCNA, MCM6, UCHL1, VHL, SP1, TTF1, HIST3H2BB, HDAC1, ARFIP2, GGA1, WRN, TP63, NCL, PPP1CB, PPP1CC, COMMD1, TRADD, UBE2I, CUL2, COPS5, SENP3, CDK5RAP3, CTBP2, RNF2, PIAS2, MYC, BRCA1, IKBKB, GGA3, CDKN2AIP, NMI, ATR, MYCN, HIF1A, E2F1, EGR1, SLC4A1, ZNF420, SIVA1, GMNN, ORC4, CDC6, CDC5L, CDC45, CDC7, MCM2, MCM10, MCM5, MAPK8, MAPK10, DEAF1, TDRD7, CRELD2, HNRNPU, FN1, PRKCA, DYRK1B, HIPK4, CDK11A, CLK2, UBE4B, USP26, SNRPA, TUBA1C, TUBB4B, TUBA1A, TUBB, HSPA9, SNRPB, RUVBL2, RIN2, PDCD6, MMRN1, MYL12A, MTR, HNRNPC, HSPA4, HSPA8, HSP90AB1, HSP90AA1, GAPDH, EPHA3, EEF2, ACLY, ACTN4, ACTG1, ACTB, HNRNPA2B1, BRK1, ACTA1, ACTBL2, CSTF2, LSM8, NCKAP1, RPP38, GNL3, DGCR8, BCL2L1, C1QBP, BECN1, RELA, MOV10, NXF1, PA2G4, ZBTB17, ANGPTL4, CASC3, NAT2, WHSC1L1, MYO1C, IQGAP1, MIS12, BAG6, CFAP97, TRIM28, PML, KAT2B, GLTSCR2, RRM2, IGF1R, PTEN, UBC, ANKRA2, ASPRV1, AZIN1, ANAPC15, ZGRF1, CCNDBP1, CENPA, EFHC2, EXOC2, HLA-DOB, MAF1, MGC34796, PTP4A3, RBM26, SIX2, UBL7, VAMP1, ZNF687, ZUFSP | MGA | E2F1, E2F3, E2F4, CBX3, MAX, PCGF3, PCGF6, RNF2, CBX2, CBX4, RYBP, YAF2, CD2BP2, SMAD1, LSM8, HIST3H3, OBSL1, EED, PSME3, RFPL4B, E2F6, WBP2NL, WDR5, CARD8, LTBR, PSMC3, MIER2, UNK, NIN, HIST1H3E, HDAC1, ZMYND8, KDM5C, ALKBH3, RC3H1, ATOH1, L3MBTL2, ZNF692, KLHL40, MLX, CDC16, CDH19, ASB6, DYNC1I1, CYLD |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CDKN2A_MGA |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CDKN2A_MGA |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CDKN2A | C1835044 | MELANOMA, CUTANEOUS MALIGNANT, 2 | 11 | CTD_human;UNIPROT |
Hgene | CDKN2A | C0024121 | Lung Neoplasms | 4 | CTD_human |
Hgene | CDKN2A | C0011570 | Mental Depression | 3 | PSYGENET |
Hgene | CDKN2A | C0011581 | Depressive disorder | 3 | PSYGENET |
Hgene | CDKN2A | C0023903 | Liver neoplasms | 3 | CTD_human |
Hgene | CDKN2A | C0005695 | Bladder Neoplasm | 2 | CTD_human |
Hgene | CDKN2A | C0006118 | Brain Neoplasms | 2 | CTD_human |
Hgene | CDKN2A | C0007131 | Non-Small Cell Lung Carcinoma | 2 | CTD_human |
Hgene | CDKN2A | C0017638 | Glioma | 2 | CTD_human |
Hgene | CDKN2A | C0030297 | Pancreatic Neoplasm | 2 | CTD_human |
Hgene | CDKN2A | C0040715 | Chromosomal translocation | 2 | CTD_human |
Hgene | CDKN2A | C0041696 | Unipolar Depression | 2 | PSYGENET |
Hgene | CDKN2A | C0345967 | Malignant mesothelioma | 2 | CTD_human |
Hgene | CDKN2A | C1168401 | Squamous cell carcinoma of the head and neck | 2 | CTD_human |
Hgene | CDKN2A | C1269683 | Major Depressive Disorder | 2 | PSYGENET |
Hgene | CDKN2A | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | CDKN2A | C0001624 | Adrenal Gland Neoplasms | 1 | CTD_human |
Hgene | CDKN2A | C0007137 | Squamous cell carcinoma | 1 | CTD_human;HPO |
Hgene | CDKN2A | C0008628 | Chromosome Deletion | 1 | CTD_human |
Hgene | CDKN2A | C0014859 | Esophageal Neoplasms | 1 | CTD_human |
Hgene | CDKN2A | C0017601 | Glaucoma | 1 | CTD_human |
Hgene | CDKN2A | C0022783 | Vulvar Lichen Sclerosus | 1 | CTD_human |
Hgene | CDKN2A | C0024299 | Lymphoma | 1 | CTD_human |
Hgene | CDKN2A | C0025202 | melanoma | 1 | CTD_human;HPO |
Hgene | CDKN2A | C0025500 | Mesothelioma | 1 | CTD_human |
Hgene | CDKN2A | C0026640 | Mouth Neoplasms | 1 | CTD_human |
Hgene | CDKN2A | C0026764 | Multiple Myeloma | 1 | CTD_human |
Hgene | CDKN2A | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | CDKN2A | C0027819 | Neuroblastoma | 1 | CTD_human |
Hgene | CDKN2A | C0031117 | Peripheral Neuropathy | 1 | CTD_human |
Hgene | CDKN2A | C0032927 | Precancerous Conditions | 1 | CTD_human |
Hgene | CDKN2A | C0036920 | Sezary Syndrome | 1 | CTD_human |
Hgene | CDKN2A | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | CDKN2A | C0040100 | Thymoma | 1 | CTD_human |
Hgene | CDKN2A | C0041107 | Trisomy | 1 | CTD_human |
Hgene | CDKN2A | C0042065 | Genitourinary Neoplasms | 1 | CTD_human |
Hgene | CDKN2A | C0079744 | Diffuse Large B-Cell Lymphoma | 1 | CTD_human |
Hgene | CDKN2A | C0079773 | Lymphoma, T-Cell, Cutaneous | 1 | CTD_human |
Hgene | CDKN2A | C0151779 | Cutaneous Melanoma | 1 | CTD_human |
Hgene | CDKN2A | C0206686 | Adrenocortical carcinoma | 1 | CTD_human |
Hgene | CDKN2A | C0206727 | Nerve Sheath Tumors | 1 | CTD_human |
Hgene | CDKN2A | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
Hgene | CDKN2A | C0279628 | Adenocarcinoma Of Esophagus | 1 | CTD_human |
Hgene | CDKN2A | C0596263 | Carcinogenesis | 1 | CTD_human |
Hgene | CDKN2A | C0677866 | Brain Stem Neoplasms | 1 | CTD_human |
Hgene | CDKN2A | C0887833 | Carcinoma, Pancreatic Ductal | 1 | CTD_human |
Hgene | CDKN2A | C1449861 | Micronuclei, Chromosome-Defective | 1 | CTD_human |
Hgene | CDKN2A | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | CDKN2A | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1 | CTD_human |
Hgene | CDKN2A | C2239176 | Liver carcinoma | 1 | CTD_human |
Hgene | CDKN2A | C2931822 | Nasopharyngeal carcinoma | 1 | CTD_human |
Tgene | MGA | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
Tgene | MGA | C0023485 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | CTD_human |
Tgene | MGA | C0079772 | T-Cell Lymphoma | 1 | CTD_human |